期刊文献+

二甲双胍抑制血管紧张素Ⅱ诱导的成年大鼠心脏成纤维细胞增殖 被引量:2

Metformin Inhibits Angiotensin Ⅱ-induced Proliferation of Adult Rat Cardiac Fibroblasts
下载PDF
导出
摘要 目的观察二甲双胍对血管紧张素Ⅱ(AngⅡ)诱导的成年大鼠心脏成纤维细胞(CF)增殖的影响,并探讨其可能机制。方法通过胰酶、胶原酶Ⅱ联合消化法获取成年大鼠CF,AngⅡ(100nmol/L)刺激CF建立细胞增殖模型,并给予不同浓度(10、50及200μmol/L)二甲双胍进行干预。采用噻唑蓝法观察CF的增殖情况,EdU掺入法测定CF的DNA合成能力。免疫印迹法检测内皮型一氧化氮合酶(eNOS)、磷酸化内皮型一氧化氮合酶(peNOS)蛋白表达情况,硝酸还原酶法测定CF培养上清一氧化氮(NO)含量。结果AngⅡ刺激48h能够明显促进成年大鼠CF增殖(P<0.05),二甲双胍呈浓度依赖性抑制AngⅡ诱导的CF增殖,二甲双胍呈浓度依赖性增加CF内eNOS磷酸化水平和NO含量(P<0.05),eNOS抑制剂N-硝基-L-精氨酸甲酯(L-NAME)能阻断二甲双胍抑制AngⅡ诱导的CF增殖的作用(P<0.05)。结论二甲双胍能抑制AngⅡ诱导的成年大鼠CF增殖,与二甲双胍激活CF内eNOS/NO通路有关。 Aim To investigate the effect of metformin on angiotensin Ⅱ(AngⅡ)-induced proliferation of adult rat cardiac fibroblasts(CF) and its underlying mechanism.Methods The adult rat CF was isolated by a combination of trypsin and collagenase Ⅱ digestion.The cell proliferation was induced by AngⅡ(100 nmol / L) stimulation,and the CF was treated with metformin in different concentrations(10,50,and 200 μmol / L).The proliferation of CF was evaluated by MTT assay,and the DNA synthesis was detected by Ed U incorporation.The expression of endothelial nitric oxide synthase(eNOS) and phosphorylated endothelial nitric oxide synthase(p-eNOS) were detected by Western blot.The level of NO in CF culture supernatant fluids was measured by nitrate reductase method.Results Stimulation with AngⅡ for 48 h induced the proliferation of adult rat CF,and this effect was inhibited by pretreatment of CF with metformin in a concentration-dependent manner.Metformin significantly increased the phosphorylation level of eNOS in CF as well as the level of NO in cell culture supernatant fluids in a concentration-dependent manner.In addition,pretreatment of CF with eNOS inhibitor L-NAME markedly attenuated the inhibitory effect of metformin on AngⅡ-induced cell proliferation.Conclusion Metformin inhibits AngⅡ-induced proliferation of adult rat CF,and this effect may be associated with the activation of the eNOS / NO pathway.
出处 《中国动脉硬化杂志》 CAS 北大核心 2015年第7期663-667,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金资助项目(81000055 81070195)
关键词 二甲双胍 心脏成纤维细胞 血管紧张素Ⅱ 一氧化氮 内皮型一氧化氮合酶 Metformin Cardiac Fibroblast Angiotensin Ⅱ Nitric Oxide Endothelial Nitric Oxide Synthase
  • 相关文献

参考文献15

  • 1Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis[J]. Cell Mol Life Sei, 2014, 71 (4) : 549-574.
  • 2唐惠芳,吴书林,邓春玉.辛伐他汀减轻舒张功能不全心力衰竭大鼠心肌纤维化[J].中国动脉硬化杂志,2012,20(11):976-980. 被引量:2
  • 3Sasaki H, Asanuma H, Fujita M, et al. Mefformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase [J]. Circulation, 2009, 119 (19) : 2 568-577.
  • 4Xiao H, Ma X, Feng W, et al. Mefformin attenuates cardiac fibrosis by inhibiting the TGF betal-Smad3 signalling pathway [J]. Cardio- vasc Res, 2010, 87 (3) : 504-513.
  • 5Teunissen BE, Smeets PJ, Willemsen PH, et al. Activation of PP-ARdelta inhibits cardiac fibroblast proliferation and the transdifferen- tiation into myofibroblasts [J].Cardiovasc Res, 2007, 75 ( 3 ) : 519-529.
  • 6UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)[J]. Lancet, 1998, 352 (9131) : 854-865.
  • 7Eurich DT, McAlister FA, Blackburn DF, et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure : sys- tematic review[J]. BMJ, 2007, 335 (7618) : 497.
  • 8Yin M, van der Horst IC, van Melle JP, et al. Mefformin improves cardiac function in a nondiabetie rat model of post-MI heart failure [J]. Am J Physiol Heart Cire Physiol, 2011, 301 (2): H 459-468.
  • 9Leask A. Potential therapeutic targets for cardiac fibrosis : TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast aetivation[J]. Cire Res, 2010, 106 (11) : 1 675-680.
  • 10Musi N, Hirshman MF, Nygren J, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes[J]. Diabetes, 2002, 51 (7) : 2 074-081.

二级参考文献40

  • 1白江涛,陆凤翔,许迪,陈莉,周蕾,雍永宏.阿托伐他汀对心肌肥厚大鼠细胞外基质重塑的抑制作用(英文)[J].高血压杂志,2004,12(5):447-451. 被引量:3
  • 2高春恒,张平洋,朱向明,杨解人,汪峰.辛伐他汀对SHR心肌组织SOD、MDA、NOS、NO及心肌间质胶原含量的影响[J].高血压杂志,2004,12(6):537-541. 被引量:4
  • 3Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction[J]. N EnglJ Med, 2006, 355 (3):251-259.
  • 4Tehrani F, Morrissey R, Phan A, et al. Stalin therapy in patients with diastolic heart failure [J ]. Clin Cardiol, 2010, 33 (4) : E1-E5.
  • 5Fukuta H, Sane DC, Brucks S, et al. Statin therapy may be associated with lower mortality in patients with diastolic' heart failure: a preliminary report[ J ]. Circulation, 2005, 112 (3): 357-363.
  • 6Roik M, Scisto P, Kochanowski J, et al. Tako-tsubo-like transient left ventricular dysfunction-a new cause of dias- tolic heart failure [ J]. Int J Cardiol, 2008, 127 (2): e102-e104.
  • 7Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats [ J]. Circulation, 2002, 106 (1) : 130-135.
  • 8Bayorh MA, Ganafa AA, Eatman D, et al. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension[J]. Am J Hypertens, 2005, 18 ( 11 ) : 1 496-502.
  • 9Reed AL, Tanaka A, Sorescu D, et al. Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse [J]. Am J Physiol Heart Circ Physiol, 2011, 301 (3) : H 824-831.
  • 10Karaahmet T, Tigen K, Dundar C, et al. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy [ J ]. Echocardiography, 2010, 27 (8): 954-960.

共引文献9

同被引文献17

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部